Qingjun Pan
Impact in
- Epidemiology top 2%
- Autophagy in Disease and Therapy
- Nephrology top 2%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Papers in
- Rheumatology 32
- Systemic Lupus Erythematosus Research 30
- Nephrology 16
- Renal Diseases and Glomerulopathies 8
- Acute Kidney Injury Research 4
- Chronic Kidney Disease and Diabetes 3
- Co-authors
- Jialu Liu (33 shared papers)Chen Yang (21 shared papers)Huafeng Liu (13 shared papers)Fengbiao Guo (14 shared papers)Quanren Pan (10 shared papers)Aifen Li (7 shared papers)Ning An (12 shared papers)Jiaxuan Chen (7 shared papers)
- Journals
- Frontiers in Immunology (11 papers)Journal of Cellular and Molecular Medicine (6 papers)Cellular Physiology and Biochemistry (4 papers)Biomedicine & Pharmacotherapy (4 papers)Frontiers in Physiology (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qingjun Pan
84 papers receiving 3.9k citations
Qingjun Pan's Hit Papers
Peers
Comparison fields: 5 of 123
- Epidemiology 1.3k
- Nephrology 375
- Rheumatology 450
- Aging 42
- Genetics 130
Countries citing papers authored by Qingjun Pan
This map shows the geographic impact of Qingjun Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingjun Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingjun Pan more than expected).
Fields of papers citing papers by Qingjun Pan
This network shows the impact of papers produced by Qingjun Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingjun Pan. The network helps show where Qingjun Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingjun Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Hit paper breakdown → | 2021 | 2067 |
| 2 | The development and improvement of immunodeficient mice and humanized immune system mouse models Hit paper breakdown → | 2022 | 116 |
| 3 | 2015 | 114 | |
| 4 | 2021 | 100 | |
| 5 | 2013 | 87 | |
| 6 | 2017 | 85 | |
| 7 | 2021 | 85 | |
| 8 | 2019 | 73 | |
| 9 | 2018 | 64 | |
| 10 | 2020 | 63 | |
| 11 | 2017 | 60 | |
| 12 | 2020 | 53 | |
| 13 | 2018 | 49 | |
| 14 | 2021 | 48 | |
| 15 | 2019 | 46 | |
| 16 | 2020 | 46 | |
| 17 | 2022 | 40 | |
| 18 | 2018 | 38 | |
| 19 | 2020 | 36 | |
| 20 | 2022 | 35 |
About Qingjun Pan
Qingjun Pan is a scholar working on Rheumatology, Nephrology, Epidemiology, Immunology and Genetics, having authored 87 papers that have together received 4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (30 papers), Autophagy in Disease and Therapy (13 papers), Renal Diseases and Glomerulopathies (8 papers), Acute Kidney Injury Research (4 papers), Immune Response and Inflammation (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Mast cells and histamine (3 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). The work is most often cited by research in Epidemiology (1.3k citations), Nephrology (375 citations), Rheumatology (450 citations), Aging (42 citations) and Genetics (130 citations). Qingjun Pan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jialu Liu, Chen Yang, Huafeng Liu, Fengbiao Guo, Quanren Pan, Aifen Li, Ning An, Jiaxuan Chen, Wei Jing Liu and Hong-Luan Wu. Their work appears in journals such as Frontiers in Immunology, Journal of Cellular and Molecular Medicine, Cellular Physiology and Biochemistry, Biomedicine & Pharmacotherapy and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.